Post Marketing Surveillance on Long-term Use With Norditropin ® (Short Stature Due to Noonan Syndrome)
Conditions: Genetic Disorder; Noonan Syndrome Intervention: Drug: Somatropin Sponsor: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2018 Category: Research Source Type: clinical trials
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome
Condition: Noonan SyndromeInterventions: Drug: Simvastatin; Drug: PlaceboSponsor: University Hospital, ToulouseNot yet recruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2016 Category: Research Source Type: clinical trials